| # | Name | Compound Key | Action Type | Relation | Activity Value | Units | Assay ID | Assay Description | Comment | Assay | Assay Organism | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1. |  ALA1648 | israpidine | Activity | 0 | ALA2416240 | Active | Rattus norvegicus | |||||
| 2. | ALA1648 | israpidine | IC50 | = | 0.107 | uM | ALA2399368 | 6.97 | nM | Oryctolagus cuniculus | ||
| 3. | ALA1648 | israpidine | IC50 | = | 0.221 | uM | ALA2399369 | 6.66 | nM | Rattus norvegicus | ||
| 4. | ALA1648 | israpidine | Ratio IC50 | = | 0.5 | ALA2399367 | ||||||
| 5. | ALA1648 | israpidine | Selectivity ratio | = | 0.69 | ALA2399254 | ||||||
| 6. | ALA1648 | israpidine | Ratio IC50 | <= | 2 | ALA2384263 | ||||||
| 7. | ALA1648 | israpidine | Potency | 29.855 | uM | ALA2354254 | inconclusive | nM | Homo sapiens | |||
| 8. | ALA1648 | israpidine | Activity | 0 | ALA2076063 | inhibitor [+] | Mus musculus | |||||
| 9. | ALA1648 | israpidine | Potency | 26.609 | uM | ALA2354221 | inconclusive | nM | Homo sapiens | |||
| 10. | ALA1648 | israpidine | Retention_time | = | 7 | min | ALA3062764 | min | Homo sapiens | |||
| 11. | ALA1648 | israpidine | Biotransformation | 0 | ALA5303594 | The Percentage Of Consumption Of The Drug Isradipine I.E. 25.843 % Is Lower Than The Drug Adaptive Fc Threshold 58.052%. No Significant Biotransformation Is Detected. | ||||||
| 12. | ALA1648 | israpidine | Biotransformation | 0 | ALA5303593 | The Percentage Of Consumption Of The Drug Isradipine I.E. 28.104 % Is Lower Than The Drug Adaptive Fc Threshold 58.052%. No Significant Biotransformation Is Detected. | ||||||
| 13. | ALA1648 | israpidine | Biotransformation | 0 | ALA5303592 | The Percentage Of Consumption Of The Drug Isradipine I.E. 30.014 % Is Lower Than The Drug Adaptive Fc Threshold 58.052%. No Significant Biotransformation Is Detected. | ||||||
| 14. | ALA1648 | israpidine | Biotransformation | 0 | ALA5303591 | The Percentage Of Consumption Of The Drug Isradipine I.E. 48.568 % Is Lower Than The Drug Adaptive Fc Threshold 58.052%. No Significant Biotransformation Is Detected. | ||||||
| 15. | ALA1648 | israpidine | Biotransformation | 0 | ALA5303590 | The Percentage Of Consumption Of The Drug Isradipine I.E. 39.865 % Is Lower Than The Drug Adaptive Fc Threshold 58.052%. No Significant Biotransformation Is Detected. | ||||||
| 16. | ALA1648 | israpidine | Biotransformation | 0 | ALA5303580 | The Percentage Of Consumption Of The Drug Isradipine I.E. 20.121 % Is Lower Than The Drug Adaptive Fc Threshold 58.052%. No Significant Biotransformation Is Detected. | ||||||
| 17. | ALA1648 | israpidine | Biotransformation | 0 | ALA5303648 | The Percentage Of Consumption Of The Drug Isradipine I.E. 0 % Is Lower Than The Drug Adaptive Fc Threshold 58.052%. No Significant Biotransformation Is Detected. | ||||||
| 18. | ALA1648 | israpidine | Biotransformation | 0 | ALA5303589 | The Percentage Of Consumption Of The Drug Isradipine I.E. 0 % Is Lower Than The Drug Adaptive Fc Threshold 58.052%. No Significant Biotransformation Is Detected. | ||||||
| 19. | ALA1648 | israpidine | Biotransformation | 0 | ALA5303601 | The Percentage Of Consumption Of The Drug Isradipine I.E. 29.401 % Is Lower Than The Drug Adaptive Fc Threshold 58.052%. No Significant Biotransformation Is Detected. | ||||||
| 20. | ALA1648 | israpidine | Biotransformation | 0 | ALA5303600 | The Percentage Of Consumption Of The Drug Isradipine I.E. 22.509 % Is Lower Than The Drug Adaptive Fc Threshold 58.052%. No Significant Biotransformation Is Detected. |
The page will load shortly, Thanks for your patience!